Mineralys Therapeutics, Inc. is a biopharmaceutical company developing medicines targeting diseases driven by dysregulated aldosterone. Its lead product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor (ASI) being developed for hypertension, chronic kidney disease (CKD), and obstructive sleep apnea (OSA). The company submitted an NDA in December 2025 for lorundrostat for hypertension treatment, with an FDA PDUFA target action date of December 22, 2026.
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001933414-26-000056 | EDGAR | 77K words |
| 2025-02-12 | 2024-12-31 | 0001933414-25-000009 | EDGAR | 80K words |
| 2024-03-21 | 2023-12-31 | 0001628280-24-012358 | EDGAR | 78K words |
| 2023-03-15 | 2022-12-31 | 0001933414-23-000012 | EDGAR | 96K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001933414-26-000114 | EDGAR | 96K words |
| 2025-11-10 | 2025-09-30 | 0001933414-25-000142 | EDGAR | 21K words |
| 2025-08-12 | 2025-06-30 | 0001933414-25-000090 | EDGAR | 19K words |
| 2025-05-12 | 2025-03-31 | 0001933414-25-000058 | EDGAR | 18K words |
| 2024-11-12 | 2024-09-30 | 0001933414-24-000057 | EDGAR | 17K words |
| 2024-08-13 | 2024-06-30 | 0001933414-24-000039 | EDGAR | 17K words |
| 2024-05-09 | 2024-03-31 | 0001933414-24-000016 | EDGAR | 16K words |
| 2023-11-07 | 2023-09-30 | 0001933414-23-000087 | EDGAR | 18K words |
| 2023-08-07 | 2023-06-30 | 0001933414-23-000056 | EDGAR | 17K words |
| 2023-05-15 | 2023-03-31 | 0001933414-23-000038 | EDGAR | 17K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001933414-26-000112 | EDGAR | 3K words |
| 2026-03-12 | 0001933414-26-000054 | EDGAR | 2K words |
| 2026-03-09 | 0001933414-26-000048 | EDGAR | 2K words |
| 2026-01-06 | 0001933414-26-000002 | EDGAR | 1K words |
| 2025-11-10 | 0001933414-25-000139 | EDGAR | 3K words |
| 2025-09-03 | 0001933414-25-000120 | EDGAR | 1K words |
| 2025-09-02 | 0001933414-25-000107 | EDGAR | 1K words |
| 2025-08-12 | 0001933414-25-000088 | EDGAR | 3K words |
| 2025-06-17 | 0001933414-25-000070 | EDGAR | 2K words |
| 2025-05-22 | 0001933414-25-000064 | EDGAR | 1K words |
67 total filings indexed. 43 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001933414 |
| Ticker | MLYS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://mineralystx.com |
| Listed | 2023-02-10 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MLYS (~200 tokens, structured JSON with cryptographic provenance)